Stage IV Colorectal Cancer Recruiting Phase 3 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02997228Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT StudyTreatment